Differential Transcriptional Regulation of CD161 and a Novel Gene, 197/15a , by IL-2, IL-15, and IL-12 in NK and T Cells
Abstract
Cytokine-mediated enhancement of spontaneous cytotoxicity depends, at least in part, on modulation of the expression of surface molecules responsible for recognition of target cell structures and triggering or inhibition of the cytotoxic machinery. We previously demonstrated that expression of transcription factors (e.g., Egr-1, JunB, and c-Fos) is differentially regulated by IL-2 and IL-12. Here we show that expression of CD161/NKR-P1A, a molecule involved in triggering cytotoxicity, is specifically up-regulated by IL-12. CD161 transcription, mRNA accumulation, and surface expression are increased by IL-12. Other cytokines sharing the IL-2R β- and/or common γ-chains (i.e., IL-15, IL-4, and IL-7) do not mediate these effects. In an effort to analyze the mechanisms by which IL-2, IL-12, and IL-15 differentially regulate gene transcription, we have isolated a novel gene, 197/15a, the expression of which in NK and T cells is down-regulated by IL-2 and IL-15, up-regulated by IL-12, and not affected by IL-4 and IL-7. IL-2 and IL-15 act, at least in part, repressing 197/15a transcription; their effect on 197/15a mRNA accumulation is partially independent of novel protein synthesis, likely not mediated by JunB, Bcl-2, or Bax, and requires the activity of rapamycin-sensitive molecule(s). The observation that IL-2 and IL-12 differentially modulate CD161 expression suggests the existence of cytokine-specific mechanisms of modulation of spontaneous cytotoxicity based on the regulation of expression of surface molecules involved in target cell recognition and/or triggering of the cytolytic machinery.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
PDCD4 gene expression is post-transcriptionally downregulated by microenvironmental factors such as growth factors and interleukins.
“PDCD4 gene mutations have not been found in tumor cells but gene expression was post transcriptionally downregulated by micro environmental factors such as growth factors and interleukins.”
From Control Mechanisms of the Tumor Suppressor PDCD4: Expression and Functions (2019) · cites this paper as [8]
PDCD4 expression is modulated by interleukins such as IL-2, IL-12, and IL-15.
“The expression of the gene was modulated by interleukins such as IL-2, IL-12, and IL-15 [8].”
From Control Mechanisms of the Tumor Suppressor PDCD4: Expression and Functions (2019) · cites this paper as [8]
Cites
1 retracted
Oligosaccharide ligands for NKR-P1 protein activate NK cells and cytotoxicity
Bezouška, K., Yuen, C.-T., O'Brien, J., Childs, R. A., Chai, W., Lawson, A. M., Drbal, K., Fišerová, A., Posíšil, M., & Feizi, T. (1994) · Nature · doi:10.1038/372150a0 · Cited by 250 · see citing works
RetractedDifferential Display of Eukaryotic Messenger RNA by Means of the Polymerase Chain Reaction
Liang, P., & Pardee, A. B. (1992) · Science · doi:10.1126/science.1354393 · Cited by 5,040 · see citing works
Hsieh, C.-S., Macatonia, S. E., Tripp, C. S., Wolf, S. F., O'Garra, A., & Murphy, K. M. (1993) · Science · doi:10.1126/science.8097338 · Cited by 3,134 · see citing works
Kobayashi, M., Fitz, L. J., Ryan, M., Hewick, R. M., Clark, S., Chan, S. H., Loudon, R. P., Sherman, F., PERUSSIA, B., & Trinchieri, G. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.170.3.827 · Cited by 1,953 · see citing works
Self-citationCloning of a T Cell Growth Factor that Interacts with the β Chain of the Interleukin-2 Receptor
Grabstein, K. H., Eisenman, J. R., Shanebeck, K. D., Rauch, C. T., Srinivasan, S., Fung, V., Beers, C., Richardson, J. S., Schoenborn, M. A., Ahdieh, M., et al. (1994) · Science · doi:10.1126/science.8178155 · Cited by 1,422 · see citing works
Carson, W. E., Giri, J. G., Lindemann, M. J., Linett, M. L., Ahdieh, M., Paxton, R. J., Anderson, D. M., Eisenmann, J., Grabstein, K. H., & Caligiuri, M. A. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.4.1395 · Cited by 1,094 · see citing works
Wolf, S. F., Temple, P. A., Kobayashi, M., Young, D. V., Dicig, M., Lowe, L. D., Dzialo, R., Fitz, L. J., Ferenz, C. R., & Hewick, R. M. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.9.3074 · Cited by 845 · see citing works
Phillips, J. H., & Lanier, L. L. (1986) · The Journal of Experimental Medicine · doi:10.1084/jem.164.3.814 · Cited by 693 · see citing works
A functional interleukin 12 receptor complex is composed of two β-type cytokine receptor subunits
Presky, D. H., Yang, H., Minetti, L. J., Chua, A. O., Nabavi, N., Wu, C. Y., Gately, M. K., & Gubler, U. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14002 · Cited by 689 · see citing works
Jacobson, N. G., Szabo, S. J., Weber-Nordt, R., Zhong, Z.-H., Schreiber, R. D., Darnell, J. E., Jr., & MURPHY, K. M. M. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.5.1755 · Cited by 673 · see citing works
Witthuhn, B. A., Silvennoinen, O., Miura, O., Lai, K. S., Cwik, C., Liu, E. T., & Ihle, J. N. (1994) · Nature · doi:10.1038/370153a0 · Cited by 613 · see citing works
Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2
Johnston, J. A., Kawamura, M., Kirken, R. A., Chen, Y.-Q., Blake, T. B., Shibuya, K., Ortaldo, J. R., McVicar, D. W., & O’Shea, J. J. (1994) · Nature · doi:10.1038/370151a0 · Cited by 593 · see citing works
Lanier, L. L., Chang, C., & Phillips, J. H. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.6.2417 · Cited by 420 · see citing works
PERUSSIA, B., Starr, S. E., Abraham, S. R., Fanning, V., & Trinchieri, G. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.5.2133 · Cited by 409 · see citing works
Self-citationSugamura, K., Asao, H., Kondo, M., Tanaka, N., Ishii, N., Ohbo, K., Nakamura, M., & Takeshita, T. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.179 · Cited by 407 · see citing works
Anegón, I., Cuturi, M. C., Trinchieri, G., & PERUSSIA, B. (1988) · The Journal of Experimental Medicine · doi:10.1084/jem.167.2.452 · Cited by 368 · see citing works
Self-citationShibasaki, F., Kondo, E., Akagi, T., & McKeon, F. (1997) · Nature · doi:10.1038/386728a0 · Cited by 364 · see citing works
Miyazaki, T., Liu, Z., Kawahara, A., Minami, Y., Yamada, K., Tsujimoto, Y., Barsoumian, E. L., Perlmutter, R. M., & Taniguchi, T. (1995) · Cell · doi:10.1016/0092-8674(95)90332-1 · Cited by 362 · see citing works
Mechanism of action of the immunosuppressant rapamycin
Dumont, F. J., & Su, Q. (1995) · Life Sciences · doi:10.1016/0024-3205(95)02233-3 · Cited by 357 · see citing works
Akbar, A. N., Borthwick, N., Wickremasinghe, R. G., Panayiotidis, P. G., Pilling, D., Bofill, M., Krajewski, S., Reed, J. C., & Salmon, M. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260204 · Cited by 349 · see citing works
Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation.
Linette, G. P., Li, Y., Roth, K. A., & Korsmeyer, S. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9545 · Cited by 328 · see citing works
PERUSSIA, B., Chan, S. H., D’Andrea, A., Tsuji, K., Santoli, D., Pospísil, M., Young, D., Wolf, S. F., & Trinchieri, G. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.11.3495 · Cited by 324 · see citing works
Self-citationChua, A. O., Chizzonite, R., Desai, B. B., Truitt, T., Nunes, P., Minetti, L. J., Warrier, R. R., Presky, D. H., Levine, J. F., Gately, M. K., et al. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.1.128 · Cited by 305 · see citing works
Signal Transduction during Natural Killer Cell Activation: Inside the Mind of a Killer
Leibson, P. J. (1997) · Immunity · doi:10.1016/s1074-7613(00)80441-0 · Cited by 295 · see citing works
Chan, S. H., Kobayashi, M., Santoli, D., PERUSSIA, B., & Trinchieri, G. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.1.92 · Cited by 276 · see citing works
Self-citationOlcese, L., Cambiaggi, A., Semenzato, G., Bottino, C., Moretta, A., & Vivier, É. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.11.5083 · Cited by 262 · see citing works
Components of a stat recognition code: Evidence for two layers of molecular selectivity
Schindler, U., Wu, P., Rothe, M., Brasseur, M., & McKnight, S. L. (1995) · Immunity · doi:10.1016/1074-7613(95)90013-6 · Cited by 246 · see citing works
Identification and purification of human stat proteins activated in response to interleukin-2
Hou, J., Schindler, U., Henzel, W. J., Wong, S. C., & McKnight, S. L. (1995) · Immunity · doi:10.1016/1074-7613(95)90140-x · Cited by 225 · see citing works
Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death
Shibahara, K., Asano, M., Ishida, Y., Aoki, T., Koike, T., & Honjo, T. (1995) · Gene · doi:10.1016/0378-1119(95)00607-9 · Cited by 223 · see citing works
Hsu, W., Kerppola, T. K., Chen, P., Curran, T., & Chen‐Kiang, S. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.268 · Cited by 199 · see citing works
PERUSSIA, B., Ramoni, C., Anegón, I., Cuturi, M. C., Faust, J. S., & Trinchieri, G. (1987) · PubMed · Cited by 181 · see citing works
Self-citationLymphokine-activated killer cells, natural killer cells and cytokines
PERUSSIA, B. (1991) · Current Opinion in Immunology · doi:10.1016/0952-7915(91)90076-d · Cited by 180 · see citing works
Self-citationModulation of perforin and granzyme messenger RNA expression in human natural killer cells.
Salcedo, T. W., Azzoni, L., Wolf, S. F., & PERUSSIA, B. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.5.2511 · Cited by 177 · see citing works
Self-citationExpression of Bcl-2, Bcl-x, and Bax after T cell activation and IL-2 withdrawal
Broome, H. E., Dargan, C. M., Krajewski, S., & Reed, J. C. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.5.2311 · Cited by 163 · see citing works
Alderson, M. R., Sassenfeld, H. M., & Widmer, M. B. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.172.2.577 · Cited by 156 · see citing works
Josien, R., Heslan, M., Soulillou, J., & Cuturi, M. C. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.3.467 · Cited by 152 · see citing works
Zou, J., Presky, D. H., Wu, C. Y., & Gubler, U. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.9.6073 · Cited by 139 · see citing works
Receptor-induced death in human natural killer cells: involvement of CD16.
Ortaldo, J. R., Mason, A. T., & O’Shea, J. J. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.1.339 · Cited by 135 · see citing works
Divergent functions of lectin‐like receptors on NK cells
Ryan, J. C., & Seaman, W. E. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb00941.x · Cited by 133 · see citing works
NKR-P1A is a target-specific receptor that activates natural killer cell cytotoxicity.
Ryan, J. C., Niemi, E. C., Nakamura, M. C., & Seaman, W. E. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.5.1911 · Cited by 126 · see citing works
Bennett, I. M., Zatsepina, O. G., Zamai, L., Azzoni, L., Mikheeva, T., & PERUSSIA, B. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.5.1845 · Cited by 121 · see citing works
Self-citationRenard, V., Cambiaggi, A., Vely, F., Bléry, M., Olcese, L., Olivero, S., Bouchet, M., & Vivier, É. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb00953.x · Cited by 108 · see citing works
The Gfi-1 protooncoprotein represses Bax expression and inhibits T-cell death
Grimes, H. L., Gilks, C. B., Chan, T. O., Porter, S. D., & Tsichlis, P. N. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14569 · Cited by 103 · see citing works
Trotta, R., Kanakaraj, P., & PERUSSIA, B. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.3.1027 · Cited by 90 · see citing works
Self-citationRabinowich, H., Herberman, R. B., & Whiteside, T. L. (1993) · Cellular Immunology · doi:10.1006/cimm.1993.1306 · Cited by 82 · see citing works
Armant, M. A., Delespesse, G., & Sarfati, M. (1995) · PubMed · Cited by 76 · see citing works
Ligand binding to Fc gamma R induces c-myc-dependent apoptosis in IL-2-stimulated NK cells.
Azzoni, L., Anegón, I., Calabretta, B., & PERUSSIA, B. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.2.491 · Cited by 71 · see citing works
Self-citationPromoter-specific trans-activation and inhibition mediated by JunB.
Hsu, J., Cressman, D. E., & Taub, R. (1993) · PubMed · Cited by 54 · see citing works
Expression and function of NKRP1A molecule on human monocytes and dendritic cells
Poggi, A. D., Rubartelli, A., Moretta, L., & Zocchi, M. R. (1997) · European Journal of Immunology · doi:10.1002/eji.1830271132 · Cited by 53 · see citing works
NK cell recognition of major histocompatibility complex class I molecules
Lanier, L. L., & Phillips, J. H. (1995) · Seminars in Immunology · doi:10.1006/smim.1995.0011 · Cited by 39 · see citing works
LORENZ, H. ‐., Hieronymus, T., Grünke, M., Manger, B., & Kalden, J. R. (1997) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1997.d01-443.x · Cited by 35 · see citing works
Molecular Cloning of the Genes Suppressed in RVC Lymphoma Cells by Topoisomerase Inhibitors
Onishi, Y., & Kizaki, H. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1609 · Cited by 34 · see citing works
Azzoni, L., Kanakaraj, P., Zatsepina, O. G., & PERUSSIA, B. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.8.3235 · Cited by 28 · see citing works
Self-citationAn antigen expressed in proliferating cells at late G1-S phase
Matsuhashi, S., Watanabe, T., & Hori, K. (1987) · Experimental Cell Research · doi:10.1016/0014-4827(87)90312-0 · Cited by 12 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Signaling by IL‐12 and IL‐23 and the immunoregulatory roles of STAT4
Watford, W. T., Hissong, B. D., Bream, J. H., Kanno, Y., Muul, L. M., & O’Shea, J. J. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00211.x · Cited by 570 · see citing works
The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation
Lankat–Buttgereit, B., & Göke, R. (2009) · Biology of the Cell · doi:10.1042/bc20080191 · Cited by 307 · see citing works
Cutting Edge: Lectin-Like Transcript-1 Is a Ligand for the Inhibitory Human NKR-P1A Receptor
Rosen, D. B., Bettadapura, J., Alsharifi, M., Mathew, P. A., Warren, H. S., & Lanier, L. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.12.7796 · Cited by 291 · see citing works
Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation
Cmarik, J. L., Min, H., Hegamyer, G., Zhan, S., Kulesz-Martin, M., Yoshinaga, H., Matsuhashi, S., & Colburn, N. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.14037 · Cited by 254 · see citing works
Zhang, H., Ozaki, I., Mizuta, T., Hamajima, H., Yasutake, T., Eguchi, Y., Ideguchi, H., Yamamoto, K., & Matsuhashi, S. (2006) · Oncogene · doi:10.1038/sj.onc.1209634 · Cited by 247 · see citing works
Yang, H.-S., Matthews, C. P., Clair, T., Wang, Q., Baker, A. R., Li, C.-C. H., Tan, T.-H., & Colburn, N. H. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.4.1297-1306.2006 · Cited by 202 · see citing works
Yang, H.-S., Cho, M.-H., Zakowicz, H., Hegamyer, G., Sonenberg, N., & Colburn, N. H. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.9.3894-3906.2004 · Cited by 199 · see citing works
Mudduluru, G., Medved, F., Grobholz, R., Jost, C., Gruber, A., Leupold, J. H., Post, S., Jansen, A., Colburn, N. H., & Allgayer, H. (2007) · Cancer · doi:10.1002/cncr.22983 · Cited by 196 · see citing works
Yang, H.-S., Jansen, A. P., Nair, R., Shibahara, K., Verma, A. K., Cmarik, J. L., & Colburn, N. H. (2001) · Oncogene · doi:10.1038/sj.onc.1204137 · Cited by 185 · see citing works
CD161 defines the subset of FoxP3+ T cells capable of producing proinflammatory cytokines
Pesenacker, A. M., Bending, D., Ursu, S., Wu, Q., Nistala, K., & Wedderburn, L. R. (2013) · Blood · doi:10.1182/blood-2012-08-443473 · Cited by 175 · see citing works
Rosen, D. B., Cao, W., Avery, D. T., Tangye, S. G., Liu, Y., Houchins, J. P., & Lanier, L. L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.10.6508 · Cited by 169 · see citing works
Translational Regulation of Autoimmune Inflammation and Lymphoma Genesis by Programmed Cell Death 4
Hilliard, A., Hilliard, B., Zheng, S.-J., Sun, H., Miwa, T., Song, W., Göke, R., & Chen, Y. H. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.8095 · Cited by 167 · see citing works
Leupold, J. H., Yang, H.-S., Colburn, N. H., Asangani, I., Post, S., & Allgayer, H. (2007) · Oncogene · doi:10.1038/sj.onc.1210234 · Cited by 163 · see citing works
Modeling Human Natural Killer Cell Development in the Era of Innate Lymphoid Cells
Scoville, S. D., Freud, A. G., & Caligiuri, M. A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00360 · Cited by 162 · see citing works
Ravet, S., Scott‐Algara, D., Bonnet, E., Tran, H., Tran, T., Nguyen, N. V., Truong, L. X. T., Theodorou, I. D., Barré‐Sinoussi, F., Pancino, G., et al. (2007) · Blood · doi:10.1182/blood-2006-08-040238 · Cited by 161 · see citing works
Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation
Yang, H.-S., Knies, J. L., Stark, C., & Colburn, N. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206433 · Cited by 160 · see citing works
Exosomal miR-208b related with oxaliplatin resistance promotes Treg expansion in colorectal cancer
Ning, T., Li, J., He, Y., Zhang, H., Wang, X., Deng, T., Liu, R., Li, H., Bai, M., Fan, Q., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.04.028 · Cited by 156 · see citing works
Afonja, O., Juste, D., Das, S., Matsuhashi, S., & Samuels, H. H. (2004) · Oncogene · doi:10.1038/sj.onc.1207983 · Cited by 154 · see citing works
Assarsson, E., Kambayashi, T., Sandberg, J. K., Hong, S., Taniguchi, M., Kaer, L. V., Ljunggren, H., & Chambers, B. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.7.3673 · Cited by 150 · see citing works
Control Mechanisms of the Tumor Suppressor PDCD4: Expression and Functions
Matsuhashi, S., Manirujjaman, M., Hamajima, H., & Ozaki, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092304 · Cited by 143 · see citing works
Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21Waf1/Cip1
Göke, R., Barth, P. J., Schmidt, A., Samans, B., & Lankat–Buttgereit, B. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00025.2004 · Cited by 135 · see citing works
Jansen, A. P., Camalier, C. E., Stark, C., & Colburn, N. H. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.103.3.2 · Cited by 132 · see citing works
Pdcd4, a colon cancer prognostic that is regulated by a microRNA
Allgayer, H. (2009) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2009.09.001 · Cited by 123 · see citing works
The IL-12 Signature: NK Cell Terminal CD56+high Stage and Effector Functions
Loza, M. J., & PERUSSIA, B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.1.88 · Cited by 114 · see citing works
Self-citationThe role of Pdcd4 in tumour suppression and protein translation
Wang, Q., & Yang, H. (2018) · Biology of the Cell · doi:10.1111/boc.201800014 · Cited by 113 · see citing works
Roth, P., Mittelbronn, M. G. A., Wick, W., Meyermann, R., Tatagiba, M. S., & Weller, M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4783 · Cited by 105 · see citing works
Frequent loss of PDCD4 expression in human glioma: Possible role in the tumorigenesis of glioma
Gao, F., Zhang, P., Zhou, C., Li, J., Wang, Q., Zhu, F., Ma, C., Sun, W., & Zhang, L. (2007) · Oncology Reports · doi:10.3892/or.17.1.123 · Cited by 100 · see citing works
Programmed cell death protein 4 (pdcd4): A novel target for antineoplastic therapy?
Lankat–Buttgereit, B., & Göke, R. (2003) · Biology of the Cell · doi:10.1016/j.biolcel.2003.09.003 · Cited by 94 · see citing works
DUG is a novel homologue of translation initiation factor 4G that binds eIF4A
Göke, A., Göke, R., Knolle, A., Trusheim, H., Schmidt, H., Wilmen, A., Carmody, R. J., Göke, B., & Chen, Y. H. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02129-0 · Cited by 92 · see citing works
An airbone mold-derived product, β-1,3-D-glucan, potentiates airway allergic responses
Wan, G., Li, C.-S., Guo, S.-P., Rylander, R., & Lin, R. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199908)29:08 · Cited by 56 · see citing works
Chapter 2 Cell Signaling in Protein Synthesis
Mahoney, S. J., Dempsey, J. M., & Blenis, J. (2009) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(09)90002-3 · Cited by 78 · see citing works
Investigation of NK cell function and their modulation in different malignancies
Konjević, G. M., Jurišić, V., Jović, V., Vuletić, A. M., Martinović, K. M., Radenković, S., & Spužić, I. (2012) · Immunologic Research · doi:10.1007/s12026-012-8285-7 · Cited by 77 · see citing works
Yu, H., Zeng, J., Liang, X., Wang, W., Zhou, Y., Sun, Y., Liu, S., Li, W., Chen, C., & Jia, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105306 · Cited by 76 · see citing works
Complexity and Diversity of the NKR-P1:Clr (Klrb1:Clec2) Recognition Systems
Kirkham, C. L., & Carlyle, J. R. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00214 · Cited by 73 · see citing works
CD8+CD28– T cells: Certainties and uncertainties of a prevalent human T‐cell subset
Arosa, F. A. (2002) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.2002.01057.x · Cited by 73 · see citing works
Konjević, G. M., Martinović, K. M., Jurišić, V., Babović, N. L., & Spužić, I. (2009) · Biomarkers · doi:10.1080/13547500902814658 · Cited by 69 · see citing works
NK Cell-Based Immunotherapy for Hematological Malignancies
Sivori, S., Meazza, R., Quintarelli, C., Carlomagno, S., Chiesa, M. D., Falco, M., Moretta, L., Locatelli, F., & Pende, D. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101702 · Cited by 67 · see citing works
Derré, L., Corvaisier, M., Pandolfino, M., Diez, E., Jotereau, F., & Gervois, N. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.10.4864 · Cited by 65 · see citing works
Loss of programmed cell death 4 induces apoptosis by promoting the translation of procaspase-3 mRNA
Eto, K., Goto, S., Nakashima, W., Ura, Y., & Abe, S.-I. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.126 · Cited by 64 · see citing works
Yoshinaga, H., Matsuhashi, S., Fujiyama, C., & Masaki, Z. (1999) · Pathology International · doi:10.1046/j.1440-1827.1999.00995.x · Cited by 62 · see citing works
Peripheral NK cell phenotypes: multiple changing of faces of an adapting, developing cell
PERUSSIA, B., Chen, Y., & Loza, M. J. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.07.017 · Cited by 58 · see citing works
Self-citationTissue trafficking patterns of effector memory CD4 T cells in rheumatoid arthritis.
Zhang, X., Nakajima, T., Goronzy, J. J., & Weyand, C. M. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21482 · Cited by 56 · see citing works
Programmed cell death factor 4 (PDCD4), a novel therapy target for metabolic diseases besides cancer
Lu, K., Chen, Q., Li, M., He, L., Riaz, F., Zhang, T., & Li, D. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.06.016 · Cited by 53 · see citing works
Konjević, G. M., Vuletić, A. M., Martinović, K. M., Čolović, N., Čolović, M., & Jurišić, V. (2016) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2016-203614 · Cited by 53 · see citing works
Martinović, K. M., Babović, N. L., Džodić, R. R., Jurišić, V., Matković, S., & Konjević, G. M. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0479-z · Cited by 49 · see citing works
Zhang, S., Li, J., Jiang, Y., Xu, Y., & Qin, C. (2009) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-28-71 · Cited by 47 · see citing works
Huang, D., Wei, Y., Zhu, J., & Wang, F. (2019) · Gene · doi:10.1016/j.gene.2019.143994 · Cited by 44 · see citing works
Drost, E., & MacNee, W. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200202)32:2 · Cited by 135 · see citing works
Self-citationKikuchi, A., Nieda, M., Schmidt, C., Koezuka, Y., Ishihara, S., Ishikawa, Y., Tadokoro, K., Durrant, S., Boyd, A., Juji, T., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1973 · Cited by 43 · see citing works
Soejima, H., Miyoshi, O., Yoshinaga, H., Masaki, Z., Ozaki, I., Kajiwara, S., Niikawa, N., Matsuhashi, S., & Mukai, T. (1999) · Cytogenetic and Genome Research · doi:10.1159/000015408 · Cited by 43 · see citing works
Konjević, G. M., Martinović, K. M., Vuletić, A. M., & Babović, N. L. (2010) · Melanoma Research · doi:10.1097/cmr.0b013e32833e3286 · Cited by 40 · see citing works
Matsuhashi, S., NARISAWA, Y., Ozaki, I., & Mizuta, T. (2007) · Experimental Dermatology · doi:10.1111/j.1600-0625.2006.00531.x · Cited by 39 · see citing works
Dissecting the Roles of PDCD4 in Breast Cancer
Cai, Q., Yang, H., Li, Y., & Zhu, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.855807 · Cited by 37 · see citing works
Hromadníková, I., Pírková, P., & Sedláčková, L. (2013) · Mediators of Inflammation · doi:10.1155/2013/405295 · Cited by 36 · see citing works
Supiot, S. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i21.3249 · Cited by 36 · see citing works
Konjević, G. M., Martinović, K. M., Vuletić, A. M., Jurišić, V., & Spužić, I. (2009) · The Journal of Membrane Biology · doi:10.1007/s00232-009-9191-3 · Cited by 35 · see citing works
Natural killer cell receptors: alterations and therapeutic targeting in malignancies
Konjević, G. M., Vuletić, A. M., & Martinović, K. M. (2015) · Immunologic Research · doi:10.1007/s12026-015-8695-4 · Cited by 34 · see citing works
Pdcd4 protein and mRNA level alterations do not correlate in human lung tumors
Калиниченко, С. В., Kopantzev, E. P., Korobko, E. V., Palgova, I. V., Эдуардовна, З. Л., Mv, B., Petrov, A. N., Frank, G. A., Sverdlov, E. D., & Korobko, I. V. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2008.03.022 · Cited by 33 · see citing works
Yasuda, M., Schmid, T., Rübsamen, D., Colburn, N. H., Irie, K., & Murakami, A. (2010) · Molecular Carcinogenesis · doi:10.1002/mc.20660 · Cited by 33 · see citing works
Proteome profiling of interleukin‐12 treated human T helper cells
Rosengren, A. T., Nyman, T. A., & Lahesmaa, R. (2005) · PROTEOMICS · doi:10.1002/pmic.200401151 · Cited by 33 · see citing works
Changes to the Natural Killer Cell Repertoire after Therapeutic Hepatitis B DNA Vaccination
Scott‐Algara, D., Bourgine, M., Fontaine, H., Pol, S., & Michel, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008761 · Cited by 32 · see citing works
Expression proteomics study to determine metallodrug targets and optimal drug combinations
Lee, R. F. S., Chernobrovkin, A. L., Rutishauser, D., Allardyce, C. S., Hacker, D. L., Johnsson, K., Zubarev, R. A., & Dyson, P. J. (2017) · Scientific Reports · doi:10.1038/s41598-017-01643-1 · Cited by 31 · see citing works
PDCD4 Knockdown Induces Senescence in Hepatoma Cells by Up-Regulating the p21 Expression
Guo, J., Ozaki, I., Xia, J., Kuwashiro, T., Kojima, M., Takahashi, H., Ashida, K., Anzai, K., & Matsuhashi, S. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2018.00661 · Cited by 29 · see citing works
Lankat–Buttgereit, B., Lenschen, B., Schmidt, H., & Göke, R. (2007) · APOPTOSIS · doi:10.1007/s10495-007-0153-x · Cited by 28 · see citing works
Konjević, G. M., Martinović, K. M., Vuletić, A. M., & Radenković, S. (2010) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2010.06.013 · Cited by 27 · see citing works
Natural Killer Cells and the Syndrome of Chronic Natural Killer Cell Lymphocytosis
Morice, W. G., Leibson, P. J., & Tefferi, A. (2001) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190109057982 · Cited by 25 · see citing works
Binia, A., Van Stiphout, N., Liang, L., Michel, S., Bhavsar, P. K., Fan Chung, K., Brightling, C. E., Barnes, P. J., Kabesch, M., Bush, A., et al. (2013) · Human Mutation · doi:10.1002/humu.22340 · Cited by 24 · see citing works
Leupold, J. H., Asangani, I. A., Mudduluru, G., & Allgayer, H. (2012) · Bioscience Reports · doi:10.1042/bsr20110045 · Cited by 23 · see citing works
Yamada, H., Shimada, S., Kato, E. H., Morikawa, M., Iwabuchi, K., Kishi, R., Onoé, K., & Minakami, H. (2004) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2004.00139.x · Cited by 22 · see citing works
Tarazona, R., Casado, J. G., Soto, R., DelaRosa, O., Peralbo, E., Rioja, L. F., Pe�a, J., & Solana, R. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0507-y · Cited by 21 · see citing works
Down-Regulation of PDCD4 Promotes Proliferation, Angiogenesis and Tumorigenesis in Glioma Cells
Pin, G., Huanting, L., Chengzhan, Z., Xinjuan, K., Yugong, F., Wei, L., Shifang, L., Zhaojian, L., Kun, H., Weicheng, Y., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.593685 · Cited by 18 · see citing works
“The human programmed cell death 4 (PDCD4) was considered to encode a nuclear antigen and located on chromosome 10 (Azzoni et al., 1998).”
BackgroundWu, L., Zhang, C., Zheng, X., Tian, Z., & Zhang, J. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.07.021 · Cited by 18 · see citing works
Regulation of tumor suppressor PDCD4 by novel protein kinase C isoforms
Nakashima, M., Hamajima, H., Xia, J., Iwane, S., Kwaguchi, Y., Eguchi, Y., Mizuta, T., Fujimoto, K., Ozaki, I., & Matsuhashi, S. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.05.002 · Cited by 17 · see citing works
Hayashi, A., Aishima, S., Miyasaka, Y., Nakata, K., Morimatsu, K., Oda, Y., Nagai, E., Oda, Y., Tanaka, M., & Tsuneyoshi, M. (2010) · Human Pathology · doi:10.1016/j.humpath.2010.02.019 · Cited by 17 · see citing works
Multiple Color Immunofluorescence for Cytokine Detection at the Single-Cell Level
Loza, M. J., Faust, J. S., & PERUSSIA, B. (2003) · Molecular Biotechnology · doi:10.1385/mb:23:3:245 · Cited by 16 · see citing works
Self-citationThe Role of Activating and Inhibitory NK Cell Receptors in Antitumor Immune Response
Konjević, G. M., Vuletić, A. M., Martinović, K. M., & Džodić, R. R. (2017) · InTech eBooks · doi:10.5772/intechopen.69729 · Cited by 15 · see citing works
Pdcd4 tumor suppressor: Properties, functions, and possible applications in oncology
Вихрева, П. Н., Shepelev, M. V., Korobko, E. V., & Korobko, I. V. (2010) · Molecular Genetics Microbiology and Virology · doi:10.3103/s0891416810020011 · Cited by 13 · see citing works
Wang, M., Shi, Q., Zhang, R., Qiu, H., Mao, D., & Long, F. (2017) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2017/9819350 · Cited by 13 · see citing works
Santos‐Juanes, J., Fernández‐Vega, I., Lorenzo‐Herrero, S., Sordo‐Bahamonde, C., Martínez‐Camblor, P., Garcia-Pedrero, J. M., Vivanco, B., Galache, C., Vázquez‐López, F., Gonzalez, S. R., et al. (2019) · Archives of Dermatological Research · doi:10.1007/s00403-019-01916-x · Cited by 13 · see citing works
Ferris, W. F. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.903374 · Cited by 12 · see citing works
Białoszewska, A., Olkowska‐Truchanowicz, J., Bocian, K., Osiecka‐Iwan, A., Czop, A., Kiéda, C., & Malejczyk, J. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700387 · Cited by 12 · see citing works
Cytoplasmic localization of programmed cell death 4 contributes to its anti-apoptotic function
Takaki, S., & Eto, K. (2018) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-018-3322-z · Cited by 10 · see citing works
Eto, K., Eda, K., Hayano, M., Goto, S., Nagao, K., Kawasaki, T., Kashimura, H., Tarui, H., Nishimura, O., Agata, K., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.018622 · Cited by 9 · see citing works
Cao, B., Chen, X., Li, Y., Zhou, T., Chen, N., Guo, Y., Zhao, M., Guo, C., Shi, Y., Wang, Q., et al. (2024) · npj Parkinson's Disease · doi:10.1038/s41531-024-00760-9 · Cited by 8 · see citing works
Differential effects of PDCD4 depletion on protein synthesis in myoblast and myotubes
Kakade, D., Islam, N., Maeda, N., & Adegoke, O. A. J. (2014) · BMC Cell Biology · doi:10.1186/1471-2121-15-2 · Cited by 8 · see citing works
Chen, G., Li, P.-H., He, J., Su, Y., Chen, H.-J., Dong, J., Huang, Y., Huang, X., Jiang, Y., Qin, Q., et al. (2021) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2021.104013 · Cited by 8 · see citing works
Konjević, G. M., Vuletić, A. M., Martinović, K. M., Krivokuća, A., Jankovic, R. N., & Babović, N. L. (2017) · The Journal of Membrane Biology · doi:10.1007/s00232-017-9977-7 · Cited by 8 · see citing works
C‐type lectin‐like CD161 is not a co‐signalling receptor in gluten‐reactive CD4 + T cells
Wyrożemski, Ł., Sollid, L. M., & Qiao, S. (2020) · Scandinavian Journal of Immunology · doi:10.1111/sji.13016 · Cited by 7 · see citing works
Martinović, K. M., Milićević, M., Larsen, A. K., Džodić, R. R., Jurišić, V., Konjević, G. M., & Vuletić, A. M. (2019) · European Cytokine Network · doi:10.1684/ecn.2019.0440 · Cited by 7 · see citing works
Yasuda, M. T., Irie, K., & Murakami, A. (2010) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.90892 · Cited by 5 · see citing works
Multiple Color Immunofluorescence for Cytokine Detection at the Single Cell Level
Loza, M. J., Faust, J. S., & PERUSSIA, B. (2003) · Humana Press eBooks · doi:10.1385/1-59259-044-6:193 · Cited by 5 · see citing works
Self-citationMoreira-Silva, E. A. D. S., Silva, D. C. M., Gomes, J. D. A. S., da Fonseca, F. G., & Corrêa‐Oliveira, R. (2014) · Virus Research · doi:10.1016/j.virusres.2014.02.001 · Cited by 3 · see citing works
Su, Q., Li, L., Zhao, J., Sun, Y., & Yang, H. (2017) · Oncotarget · doi:10.18632/oncotarget.20975 · Cited by 3 · see citing works
Yang, H., Wang, Q., Bajer, M. M., & Schmid, T. (2014) · Springer eBooks · doi:10.1007/978-94-017-9078-9_6 · Cited by 3 · see citing works
Reactive Oxygen Species in Plasma Medical Science (PAM and Cancer Therapy)
(2018) · Elsevier eBooks · doi:10.1016/b978-0-12-815004-7.00005-6 · Cited by 2 · see citing works
PDCD4: A critical regulator in leukemic signaling networks and its therapeutic potential
Huang, J., Yin, M., Zhang, R., Xia, Y., & Zhang, X. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-11331-3 · Cited by 1 · see citing works
Innate lymphoid cells: unsung heroes or villains in multiple sclerosis pathogenesis?
Aliyu, M., Saboor-Yaraghi, A. A., Sahraian, M. A., Noorbakhsh, F., Adamu, A.-M. Y., Sharif, A. A., & Abdulqadir, Z. A. (2026) · Immunologic Research · doi:10.1007/s12026-025-09734-2 · Cited by 1 · see citing works
Dependency of Ly49 Recognition on Anchor Residues of Peptide Bound to MHC-I
Marquez, E. A. (2015) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3x34n08h · Cited by 1 · see citing works
PERUSSIA, B., & Loza, M. J. (2005) · Elsevier eBooks · doi:10.1016/b978-012455900-4/50283-x · Cited by 1 · see citing works
Self-citationKLRB Receptor Family and Human Early Activation Antigen (CD69)
Gupta, R. K., & Gupta, G. (2012) · Springer eBooks · doi:10.1007/978-3-7091-1065-2_29
- Authors
- Azzoni, L., Zatsepina, O., Abebe, B., Bennett, I. M., Kanakaraj, P., & Perussia, B.
- Affiliations
- Thomas Jefferson University (US)
- Sidney Kimmel Cancer Center (US)
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-10-01
- Volume
- 161
- Issue
- 7
- Pages
- 3493-3500
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2098965772
- Cited by
- 105
- References
- 54
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1 · 2022: 2 · 2021: 2 · 2020: 3 · 2019: 6 · 2018: 3 · 2017: 8 · 2016: 1 · 2015: 3 · 2014: 5 · 2013: 5 · 2012: 3
- FWCI
- 0.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ca037155-13, 5r01ca045284-11)
- National Cancer Institute (T32CA09683, CA 45284, CA37155, T32CA009683)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
- Keywords
- CD161, NKR-P1A, IL-12, interleukin-2, IL-15, natural killer cells, T cells, transcriptional regulation, spontaneous cytotoxicity, cytokine signaling, JunB, EGR1, c-fos, surface molecule expression
- MeSH terms
- Amino Acid Sequence, Animals, Antigens, Surface, Clone Cells, Cytotoxicity, Immunologic, Gene Expression Regulation, Humans, Interleukin-2, Interleukins, Killer Cells, Natural, Molecular Sequence Data, Proteins, Sequence Homology, Nucleic Acid, Transcription, Genetic, Protein Biosynthesis, Tumor Cells, Cultured, T-Lymphocyte Subsets, Cytokines, RNA-Binding Proteins, Receptors, Interleukin, Interleukin-12, Cell Cycle Proteins, Interleukin-15, Lectins, C-Type, Apoptosis Regulatory Proteins, Mice, NK Cell Lectin-Like Receptor Subfamily B
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review